Form 6-K GW PHARMACEUTICALS PLC For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GW Pharmaceuticals plc (GWPH) Tops Q3 Loss Expectations
August 6, 2014 7:18 AM EDTGW Pharmaceuticals plc (NASDAQ: GWPH) reported Q3 EPS of $0.06, $1.14 better than the analyst estimate of ($1.08). Revenue for the quarter came in at $13 million versus the consensus estimate of $12.88 million.
For earnings history and earnings-related data on GW Pharmaceuticals plc (GWPH) click here.
... More